Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | EPHX1 | P07099 | 7/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chlorhexidine SCHEMBL21680261 | 1.00 | LMNA (0.55) | LMNASMN1; SMN2EPHX1ALDH1A1HTT | |
| SCHEMBL12522772 | 1.00 | LMNA (0.55) | LMNASMN1; SMN2EPHX1ALDH1A1HTT | |
| SCHEMBL13400831 | 0.99 | SMN1; SMN2 (0.56) | LMNASMN1; SMN2EPHX1ALDH1A1HTT | |
| SCHEMBL10015687 | 0.94 | SMN1; SMN2 (0.61) | LMNASMN1; SMN2HTT | |
| Chlorhexidine SCHEMBL1898352 | 0.93 | LMNA (0.49) | LMNASMN1; SMN2EPHX1ALDH1A1HTT | |
| Chlorhexidine SCHEMBL14603395 | 0.93 | LMNA (0.48) | LMNASMN1; SMN2ALDH1A1HTT | |
| Chlorhexidine SCHEMBL1550787 | 0.93 | LMNA (0.46) | LMNASMN1; SMN2ALDH1A1HTT | |
| Chlorhexidine SCHEMBL3984 | 0.93 | LMNA (0.46) | LMNASMN1; SMN2ALDH1A1HTT | |
| Chlorhexidine SCHEMBL1551122 | 0.93 | LMNA (0.46) | LMNASMN1; SMN2ALDH1A1HTT | |
| SCHEMBL6365499 | 0.93 | LMNA (0.46) | LMNASMN1; SMN2ALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8450294-B2 | Shampoo compositions | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2013-05-28 | — | — | US | disclosed |
| WO-2012119155-A1 | ANTIMICROBIAL COMPOSITIONS FOR TOOTH FLUORIDATION AND REMINERALIZATION | AMERICAN DENTAL ASSOCIATION FOUNDATION (US) | 2012-09-07 | — | — | WO | disclosed |
| EP-1841402-B9 | PROCESS FOR PREPARING HYDROCOLLOIDS | LUBRIZOL ADVANCED MAT INC (US) | 2009-09-16 | — | — | EP | disclosed |
| US-20090137438-A1 | Hydrocolloids and Process Therefor | LUBRIZOL ADVANCED MATERIALS, INC. | 2009-05-28 | — | — | US | disclosed |
| EP-1841402-B1 | PROCESS FOR PREPARING HYDROCOLLOIDS | LUBRIZOL ADVANCED MAT INC (US) | 2009-04-22 | — | — | EP | disclosed |
| EP-1841402-A1 | PROCESS FOR PREPARING HYDROCOLLOIDS | Lubrizol Advanced Materials, Inc. (US) | 2007-10-10 | — | — | EP | disclosed |
| US-20070187429-A1 | Dual opening tubular dispenser | FARAHMAND BARDIA | 2007-08-16 | — | — | US | disclosed |
| WO-2006065469-A1 | PROCESS FOR PREPARING HYDROCOLLOIDS | NOVEON, INC. (US) | 2006-06-22 | — | — | WO | disclosed |
| WO-2006062792-A2 | HYDROCOLLOIDS AND PROCESS THEREFOR | NOVEON, INC. (US) | 2006-06-15 | — | — | WO | disclosed |
| EP-1639018-A1 | GALACTOMANNAN HYDROCOLLOIDS | Noveon IP Holdings Corp. (US) | 2006-03-29 | — | — | EP | disclosed |
| US-20050075497-A1 | Hydrocolloids and process therefor | LUBRIZOL ADVANCED MATERIALS, INC. | 2005-04-07 | — | — | US | disclosed |
| WO-2004113390-A1 | GALACTOMANNAN HYDROCOLLOIDS | NOVEON IP HOLDINGS CORP. (US) | 2004-12-29 | — | — | WO | disclosed |
| US-6200550-B1 | Oral care compositions comprising coenzyme Q10 | Q-PHARMA, INC. | 2001-03-13 | — | — | US | disclosed |
| EP-0575020-A1 | Non-aqueous liquid antibacterial oral composition exhibiting improved uptake on dental tissue surfaces | Colgate-Palmolive Company (US) | 1993-12-22 | — | — | EP | disclosed |
| EP-0372603-A2 | Antibacterial oral composition | Colgate-Palmolive Company (US) | 1990-06-13 | — | — | EP | disclosed |
| EP-0040738-A2 | Dentifrices | Richardson-Vicks, Inc. (US) | 1981-12-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137438-A1 | Hydrocolloids and Process Therefor | ALG1, GYPA, HSD17B7 | LMNA 2846/4885SMN1; SMN2 4513/4885EPHX1 1460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.